Stay updated with breaking news from Financing Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In conjunction with our Q2 2023 Venture Financing Report, I sat down with Steve Harrick of Institutional Venture Partners (IVP) to get his take on the state of venture capital...
Anew messenger RNA (mRNA) design tool addresses two significant obstacles to the therapeutic use of mRNA: effective protein expression and structural stability.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
In conjunction with our Q1 Venture Financing Report, I sat down with Julie Yoo of Andreessen Horowitz to get her take on the state of venture capital investing. Key...
Healthtech executives and investors gathered at Cooley’s 13th Annual Healthtech Conference in early May to discuss market trends and dealmaking, as well as celebrate CEO success...